SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Logeart Damien)
 

Sökning: WFRF:(Logeart Damien) > Are hospitalized or...

  • Maggioni, Aldo P.ANMCO Research Centre, Italy (författare)

Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

  • Artikel/kapitelEngelska2013

Förlag, utgivningsår, omfång ...

  • 2014-01-27
  • Oxford University Press (OUP): Policy B,2013
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-100031
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-100031URI
  • https://doi.org/10.1093/eurjhf/hft134DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:127425558URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding Agencies|ESC||Abbot Vascular||Bayer Pharma||BMS/Pfizer||Boehringer Ingelheim International||Daiichi Sankyo Europe||Menarini International||Novartis Pharma||Laboratoires Servier||Amgen||Boston Scientific International||MSD/Merck Co||Sanofi-Aventis Group||
  • To evaluate how recommendations of European guidelines regarding pharmacological and non-pharmacological treatments for heart failure (HF) are adopted in clinical practice. less thanbrgreater than less thanbrgreater thanThe ESC-HF Long-Term Registry is a prospective, observational study conducted in 211 Cardiology Centres of 21 European and Mediterranean countries, members of the European Society of Cardiology (ESC). From May 2011 to April 2013, a total of 12 440 patients were enrolled, 40.5 with acute HF and 59.5 with chronic HF. Intravenous treatments for acute HF were heterogeneously administered, irrespective of guideline recommendations. In chronic HF, with reduced EF, reninangiotensin system (RAS) blockers, beta-blockers, and mineralocorticoid antagonists (MRAs) were used in 92.2, 92.7, and 67.0 of patients, respectively. When reasons for non-adherence were considered, the real rate of undertreatment accounted for 3.2, 2.3, and 5.4 of the cases, respectively. About 30 of patients received the target dosage of these drugs, but a documented reason for not achieving the target dosage was reported in almost two-thirds of them. The more relevant reasons for non-implantation of a device, when clinically indicated, were related to doctor uncertainties on the indication, patient refusal, or logistical/cost issues. less thanbrgreater than less thanbrgreater thanThis pan-European registry shows that, while in patients with acute HF, a large heterogeneity of treatments exists, drug treatment of chronic HF can be considered largely adherent to recommendations of current guidelines, when the reasons for non-adherence are taken into account. Observations regarding the real possibility to adhere fully to current guidelines in daily clinical practice should be seriously considered when clinical practice guidelines have to be written.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Anker, Stefan D.Campus Virchow Klinikum, Germany (författare)
  • Dahlström, UlfÖstergötlands Läns Landsting,Linköpings universitet,Avdelningen för kardiovaskulär medicin,Hälsouniversitetet,Kardiologiska kliniken US(Swepub:liu)ulfda85 (författare)
  • Filippatos, GerasimosUniversity of Athens, Greece (författare)
  • Ponikowski, PiotrMil Hospital, Poland (författare)
  • Zannad, FaiezNancy University, France (författare)
  • Amir, OfferInstitute deBoliCardiovasc CC Iliescu, Romania (författare)
  • Chioncel, OvidiuInstitute deBoliCardiovasc CC Iliescu, Romania (författare)
  • Crespo Leiro, MarisaHospital University of A Coruna, Spain (författare)
  • Drozdz, JaroslawMedical University of Lodz, Poland (författare)
  • Erglis, AndrejsPauls Stradins Clin University Hospital, Latvia (författare)
  • Fazlibegovic, EmirClin Hospital Mostar, Bosnia and Herceg (författare)
  • Fonseca, CandidaUniversity of Nova Lisboa, Portugal (författare)
  • Fruhwald, FriedrichMedical University, Austria (författare)
  • Gatzov, PlamenUniversity Hospital Lozenets, Bulgaria (författare)
  • Goncalvesova, EvaNational Institute Cardiovasc Disease NUSCH, Slovakia (författare)
  • Hassanein, MahmoudUniversity of Alexandria, Egypt (författare)
  • Hradec, JaromirCharles University of Prague, Czech Republic (författare)
  • Kavoliuniene, AusraLithuanian University of Health Science, Lithuania (författare)
  • Lainscak, MitjaUniversity of Clin Resp and Allerg Disease Golnik, Slovenia (författare)
  • Logeart, DamienLariboisiere Hospital, France (författare)
  • Merkely, BelaSemmelweis University, Hungary (författare)
  • Metra, MarcoUniversity of Brescia, Italy (författare)
  • Persson, HansKarolinska Institutet (författare)
  • Seferovic, PetarClin Centre Serbia, Serbia (författare)
  • Temizhan, AhmetTurkey Yuksek Ihtisas Hospital, Turkey (författare)
  • Tousoulis, DimitrisUniversity of Athens, Greece (författare)
  • Tavazzi, LuigiEttore Sansavini Health Science Fdn, Italy (författare)
  • ANMCO Research Centre, ItalyCampus Virchow Klinikum, Germany (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:European Journal of Heart Failure: Oxford University Press (OUP): Policy B15:10, s. 1173-11841388-98421879-0844

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy